STOCK TITAN

Vanguard disaggregates holdings; FTRE shows 0 shares after realignment (NYSE: FTRE)

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Fortrea Holdings Inc Schedule 13G/A shows The Vanguard Group reporting 0 shares beneficially owned of Common Stock, representing 0%. The filing explains an internal realignment on January 12, 2026 that led certain Vanguard subsidiaries/divisions to report ownership separately under SEC Release No. 34-39538.

Positive

  • None.

Negative

  • None.

Insights

Vanguard reports no beneficial ownership after organizational realignment.

The filing lists an Amount beneficially owned: 0 and Percent of class: 0%, reflecting disaggregation after an internal reorganization on January 12, 2026. This means Vanguard, as reported here, does not hold beneficial voting or dispositive power over Fortrea shares.

Practical implications depend on separate filings by the disaggregated subsidiaries; subsequent amendments may show holdings shifted to named Vanguard entities.

Amendment attributes reporting change to SEC Release No. 34-39538 guidance.

The statement cites SEC Release No. 34-39538 and explains that subsidiaries or business divisions will report beneficial ownership separately. The disclosure follows the release's disaggregation approach and documents the administrative basis for the zero ownership entry.

Watch for additional Schedule 13 filings from Vanguard affiliates that reflect the redistributed positions; timing and amounts are not included here.






Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G




Comment for Type of Reporting Person: On January 12, 2026, The Vanguard Group, Inc. went through an internal realignment. In accordance with SEC Release No. 34-39538 (January 12, 1998), certain subsidiaries or business divisions of subsidiaries of The Vanguard Group, Inc., that formerly had, or were deemed to have, beneficial ownership with The Vanguard Group, Inc., will report beneficial ownership separately (on a disaggregated basis) from The Vanguard Group, Inc. in reliance on such release. These subsidiaries and/or business divisions pursue the same investment strategies as previously pursued by The Vanguard Group, Inc. prior to the realignment. Further in accordance with SEC Release No. 34-39538 (January 12, 1998), The Vanguard Group, Inc. no longer has, or is deemed to have, beneficial ownership over securities beneficially owned by such subsidiaries and/or business divisions.


SCHEDULE 13G



The Vanguard Group
Signature:Ashley Grim
Name/Title:Head of Global Fund Administration
Date:03/26/2026

FAQ

Does Vanguard own any Fortrea (FTRE) shares after this filing?

No. The filing states Amount beneficially owned: 0 and Percent of class: 0%. It attributes this to an internal realignment on January 12, 2026 that disaggregated reporting among Vanguard subsidiaries.

Why does the Schedule 13G/A show zero ownership for The Vanguard Group?

Because Vanguard underwent an internal realignment on January 12, 2026. Under SEC Release No. 34-39538, certain subsidiaries now report beneficial ownership separately, so The Vanguard Group reports 0 shares here.

Who signed the amendment reporting Vanguard's Fortrea position?

The filing is signed by Ashley Grim, listed as Head of Global Fund Administration. The signature block shows the signing date as 03/26/2026 and the reporting entity as The Vanguard Group.

Does this filing identify which Vanguard subsidiaries now report Fortrea holdings?

No. The amendment explains that subsidiaries or business divisions will report separately under SEC Release No. 34-39538 but does not name specific subsidiaries or provide replacement filing amounts in this excerpt.

Will this Schedule 13G/A change Fortrea's shareholder register or voting outcomes?

The filing only discloses reporting changes by Vanguard and lists 0 shares for The Vanguard Group. It does not state any direct effect on Fortrea's shareholder register or voting outcomes in this excerpt.
Fortrea Holdings

NASDAQ:FTRE

View FTRE Stock Overview

FTRE Rankings

FTRE Latest News

FTRE Latest SEC Filings

FTRE Stock Data

882.64M
92.95M
Biotechnology
Services-medical Laboratories
Link
United States
DURHAM